Owkin, a New York City-based AI startup, announced it is now working with the University of Pittsburgh to design and validate advanced machine learning models. Once finalized, the new models are expected to have a significant impact in areas such as clinical research and the development of pharmaceuticals.

Several healthcare industry groups are taking steps to inform their provider members to tackle the spread and risks of the new coronavirus, COVID-19.

Countless studies have explored AI’s impact on healthcare providers and the patients they serve—but what about the financial side of things? Looking purely at the bottom line, is AI a wise investment?

The Healthcare Information and Management Systems Society (HIMSS) has officially canceled its 2020 annual meeting in Orlando, Florida, due to continued concerns over the new coronavirus.

AI could provide radiologists with significant value as an advanced peer review tool, according to new findings published in Academic Radiology.

Despite international travel interruptions due to COVID-19, HIMSS20 is moving “full steam ahead as scheduled” for March 9 to 13 in Orlando.

Saykara, a Seattle-based healthcare technology company, has launched a new AI-powered solution for documenting physician-patient conversations.

AI technology could play a vital rule in the diagnosis and treatment of aggressive posterior retinopathy of prematurity (AP-ROP) in infants, according to new research published in Ophthalmology.